Telehealth has reshaped how Americans access prescription treatments — particularly for weight management, hormone optimization, and chronic condition management. But the rapid growth of direct-to-consumer telehealth platforms has also created an information gap: most consumers have no straightforward way to compare platforms on the things that matter, including what they prescribe, how their medical evaluations work, what they actually cost, and what the evidence says about the treatments they offer.
These briefings are designed to close that gap.
What Each Telehealth Briefing Covers
Platform Mechanics — How does the platform work? What is the patient intake process? Is there a synchronous consultation with a licensed prescriber, or is the evaluation asynchronous? What states does the platform serve? Understanding the operational model is the first step in evaluating whether a platform meets your needs.
Prescribing Protocols — What medications or treatments does the platform prescribe? For GLP-1 platforms: which specific medications (branded, generic, compounded) are available? For TRT platforms: what are the standard protocols and monitoring requirements? We document what each platform offers so you can compare directly.
Pricing Transparency — Telehealth pricing is often obscured behind consultations, subscriptions, and medication costs that are disclosed at different stages of the intake process. Each briefing attempts to map the full cost picture, including consultation fees, medication costs, subscription requirements, and any hidden charges identified during our evaluation.
Clinical Evidence Review — For the treatments prescribed by each platform, we examine the published clinical evidence. If a platform prescribes compounded semaglutide, for example, we assess what the research says about compounded GLP-1 formulations versus branded products — including any FDA guidance or safety considerations.
The Briefing — A structured bottom-line summary covering who the platform is designed for, what it actually costs, and what the evidence says about its core offerings.
Areas of Focus
GLP-1 and Weight Management Telehealth — Platforms prescribing semaglutide, tirzepatide, and related medications for weight management. This is the fastest-growing and most heavily marketed segment of telehealth, and it requires careful evaluation of compounding practices, prescriber qualifications, and clinical monitoring protocols.
Hormone Optimization and TRT — Platforms offering testosterone replacement therapy, hormone panels, and related treatments. These briefings examine prescribing criteria, monitoring frequency, and the clinical evidence behind the protocols used.
Virtual Primary Care and Specialty Platforms — Broader telehealth platforms offering virtual consultations across multiple specialties. These briefings assess the scope of services, prescriber qualifications, and how the virtual experience compares to traditional care settings.
Important Context
Telehealth platforms provide access to licensed prescribers, but the prescribing relationship is between you and the platform's medical provider — not between you and PVMedCenter.com. We evaluate these platforms editorially. We do not endorse, recommend, or guarantee any telehealth provider, prescriber, or treatment protocol. Any decision to pursue prescription treatment should involve a thorough conversation with a qualified healthcare provider who understands your full medical history.
Transparency note: Some telehealth briefings contain affiliate links. If you purchase through them, PVMedCenter.com may earn a commission at no extra cost to you. This does not influence our editorial evaluation. Full details: Our Standards.